Focuses on advanced heart failure care—mechanical circulatory support and transplant—chrono-cardio-oncology to reduce anthracycline cardiotoxicity, and translational human cardiac models to connect genetics with therapy. Contributes to ESC consensus work and multicenter clinical studies.